These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
321 related articles for article (PubMed ID: 32155177)
1. Development and validation of a lipogenic genes panel for diagnosis and recurrence of colorectal cancer. Gharib E; Nasrinasrabadi P; Zali MR PLoS One; 2020; 15(3):e0229864. PubMed ID: 32155177 [TBL] [Abstract][Full Text] [Related]
2. Identification and Clinical Validation of a Novel 4 Gene-Signature with Prognostic Utility in Colorectal Cancer. Ahluwalia P; Mondal AK; Bloomer C; Fulzele S; Jones K; Ananth S; Gahlay GK; Heneidi S; Rojiani AM; Kota V; Kolhe R Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31387239 [TBL] [Abstract][Full Text] [Related]
3. Survival marker genes of colorectal cancer derived from consistent transcriptomic profiling. Martinez-Romero J; Bueno-Fortes S; Martín-Merino M; Ramirez de Molina A; De Las Rivas J BMC Genomics; 2018 Dec; 19(Suppl 8):857. PubMed ID: 30537927 [TBL] [Abstract][Full Text] [Related]
4. Novel methylation gene panel in adjacent normal tissues predicts poor prognosis of colorectal cancer in Taiwan. Hsu CH; Hsiao CW; Sun CA; Wu WC; Yang T; Hu JM; Huang CH; Liao YC; Chen CY; Lin FH; Chou YC World J Gastroenterol; 2020 Jan; 26(2):154-167. PubMed ID: 31988582 [TBL] [Abstract][Full Text] [Related]
5. A network-based predictive gene expression signature for recurrence risks in stage II colorectal cancer. Yang WJ; Wang HB; Wang WD; Bai PY; Lu HX; Sun CH; Liu ZS; Guan DK; Yang GW; Zhang GL Cancer Med; 2020 Jan; 9(1):179-193. PubMed ID: 31724326 [TBL] [Abstract][Full Text] [Related]
7. Large-Scale Analysis of Gene Expression Data Reveals a Novel Gene Expression Signature Associated with Colorectal Cancer Distant Recurrence. Alajez NM PLoS One; 2016; 11(12):e0167455. PubMed ID: 27935967 [TBL] [Abstract][Full Text] [Related]
8. Investigating the diagnostic performance of HOTTIP, PVT1, and UCA1 long noncoding RNAs as a predictive panel for the screening of colorectal cancer patients with lymph node metastasis. Gharib E; Anaraki F; Baghdar K; Ghavidel P; Sadeghi H; Nasrabadi PN; Peyravian N; Aghdaei HA; Zali MR; Mojarad EN J Cell Biochem; 2019 Sep; 120(9):14780-14790. PubMed ID: 30993787 [TBL] [Abstract][Full Text] [Related]
9. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis. Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001 [TBL] [Abstract][Full Text] [Related]
10. Novel Multiple miRNA-Based Signatures for Predicting Overall Survival and Recurrence-Free Survival of Colorectal Cancer Patients. Qian J; Zeng L; Jiang X; Zhang Z; Luo X Med Sci Monit; 2019 Sep; 25():7258-7271. PubMed ID: 31560680 [TBL] [Abstract][Full Text] [Related]
11. Identification of a Novel Five-Gene Signature as a Prognostic and Diagnostic Biomarker in Colorectal Cancers. Ghatak S; Mehrabi SF; Mehdawi LM; Satapathy SR; Sjölander A Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054980 [TBL] [Abstract][Full Text] [Related]
12. A formalin-fixed paraffin-embedded (FFPE)-based prognostic signature to predict metastasis in clinically low risk stage I/II microsatellite stable colorectal cancer. Low YS; Blöcker C; McPherson JR; Tang SA; Cheng YY; Wong JYS; Chua C; Lim TKH; Tang CL; Chew MH; Tan P; Tan IB; Rozen SG; Cheah PY Cancer Lett; 2017 Sep; 403():13-20. PubMed ID: 28624625 [TBL] [Abstract][Full Text] [Related]
13. A prognostic index based on an eleven gene signature to predict systemic recurrences in colorectal cancer. Kim SK; Kim SY; Kim CW; Roh SA; Ha YJ; Lee JL; Heo H; Cho DH; Lee JS; Kim YS; Kim JC Exp Mol Med; 2019 Oct; 51(10):1-12. PubMed ID: 31578316 [TBL] [Abstract][Full Text] [Related]
14. Identification and Construction of Combinatory Cancer Hallmark-Based Gene Signature Sets to Predict Recurrence and Chemotherapy Benefit in Stage II Colorectal Cancer. Gao S; Tibiche C; Zou J; Zaman N; Trifiro M; O'Connor-McCourt M; Wang E JAMA Oncol; 2016 Jan; 2(1):37-45. PubMed ID: 26502222 [TBL] [Abstract][Full Text] [Related]
15. Identification of a metastasis-specific MicroRNA signature in human colorectal cancer. Hur K; Toiyama Y; Schetter AJ; Okugawa Y; Harris CC; Boland CR; Goel A J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25663689 [TBL] [Abstract][Full Text] [Related]
16. ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis. Agesen TH; Sveen A; Merok MA; Lind GE; Nesbakken A; Skotheim RI; Lothe RA Gut; 2012 Nov; 61(11):1560-7. PubMed ID: 22213796 [TBL] [Abstract][Full Text] [Related]
17. Discovery of a novel six-long non-coding RNA signature predicting survival of colorectal cancer patients. Fan Q; Liu B J Cell Biochem; 2018 Apr; 119(4):3574-3585. PubMed ID: 29227531 [TBL] [Abstract][Full Text] [Related]
18. Transcriptomic expression profiling identifies ITGBL1, an epithelial to mesenchymal transition (EMT)-associated gene, is a promising recurrence prediction biomarker in colorectal cancer. Matsuyama T; Ishikawa T; Takahashi N; Yamada Y; Yasuno M; Kawano T; Uetake H; Goel A Mol Cancer; 2019 Feb; 18(1):19. PubMed ID: 30717807 [TBL] [Abstract][Full Text] [Related]
19. Clinical Prognostic Significance of HOXC9 Expression in Patients with Colorectal Cancer. Hu M; Ou-Yang W; Jing D; Chen R Clin Lab; 2019 Aug; 65(8):. PubMed ID: 31414766 [TBL] [Abstract][Full Text] [Related]
20. Aberrant expression of long noncoding RNA SNHG15 correlates with liver metastasis and poor survival in colorectal cancer. Huang L; Lin H; Kang L; Huang P; Huang J; Cai J; Xian Z; Zhu P; Huang M; Wang L; Xian CJ; Wang J; Dong J J Cell Physiol; 2019 May; 234(5):7032-7039. PubMed ID: 30317592 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]